Early Biologics Support

Supporting Regulatory-Driven Excellence in Pharmaceutical and Medical Device Testing

Gateway Analytical delivers exploratory workflows using high-resolution QTOF-MS for peptide-based biologics, supporting digestion-based structural comparisons, sequence confirmation, and impurity tracking. These workflows offer detailed molecular insights critical for early development and comparability studies.

As part of our expanding capabilities, offerings include host cell protein (HCP) profiling and biologic-specific leachables analysis—ensuring comprehensive support for biologic safety, integrity, and regulatory compliance. Trust Gateway’s scientific depth and regulatory experience to advance your biologic development pipeline.

Covering every stage of the drug development journey with our state-of-the-art, FDA-inspected, cGMP-compliant facilities designed to minimize bottlenecks and maximize success.

Facebook
Twitter
LinkedIn

Early-Phase Development

Comprehensive packages designed to navigate clinical & regulatory complexities of parenteral product-package and container-closure development, from concept to market readiness.

Container Closure
Integrity Testing

Quantitative, non-destructive, deterministic leak detection technologies for products stored in vials, syringes, cartridges, flexible containers, and bottles.

Particulate
Analysis

Multi-analytical methods to count, size, and characterize visible and subvisible particulate matter in pharmaceuticals, disposable containers, single-use systems, raw materials, and medical devices.

Medical Device
Analysis

Rigorous studies focused on enumerating particulate matter and identifying potential chemical compounds that could migrate from medical devices into the environment or directly impact patient health.

Extractables
& Leachables

Studies aimed at identifying potentially harmful compounds in manufacturing components and final containers to ensure the safety and efficacy of pharmaceutical products.